307 related articles for article (PubMed ID: 23951065)
1. Clonal dissemination, emergence of mutator lineages and antibiotic resistance evolution in Pseudomonas aeruginosa cystic fibrosis chronic lung infection.
López-Causapé C; Rojo-Molinero E; Mulet X; Cabot G; Moyà B; Figuerola J; Togores B; Pérez JL; Oliver A
PLoS One; 2013; 8(8):e71001. PubMed ID: 23951065
[TBL] [Abstract][Full Text] [Related]
2. Great phenotypic and genetic variation among successive chronic Pseudomonas aeruginosa from a cystic fibrosis patient.
Lozano C; Azcona-Gutiérrez JM; Van Bambeke F; Sáenz Y
PLoS One; 2018; 13(9):e0204167. PubMed ID: 30212579
[TBL] [Abstract][Full Text] [Related]
3. Genotypic and phenotypic variation in Pseudomonas aeruginosa reveals signatures of secondary infection and mutator activity in certain cystic fibrosis patients with chronic lung infections.
Warren AE; Boulianne-Larsen CM; Chandler CB; Chiotti K; Kroll E; Miller SR; Taddei F; Sermet-Gaudelus I; Ferroni A; McInnerney K; Franklin MJ; Rosenzweig F
Infect Immun; 2011 Dec; 79(12):4802-18. PubMed ID: 21930755
[TBL] [Abstract][Full Text] [Related]
4. Genetic adaptation of Pseudomonas aeruginosa during chronic lung infection of patients with cystic fibrosis: strong and weak mutators with heterogeneous genetic backgrounds emerge in mucA and/or lasR mutants.
Ciofu O; Mandsberg LF; Bjarnsholt T; Wassermann T; Høiby N
Microbiology (Reading); 2010 Apr; 156(Pt 4):1108-1119. PubMed ID: 20019078
[TBL] [Abstract][Full Text] [Related]
5. Pseudomonas aeruginosa carbapenem resistance mechanisms in Spain: impact on the activity of imipenem, meropenem and doripenem.
Riera E; Cabot G; Mulet X; García-Castillo M; del Campo R; Juan C; Cantón R; Oliver A
J Antimicrob Chemother; 2011 Sep; 66(9):2022-7. PubMed ID: 21653605
[TBL] [Abstract][Full Text] [Related]
6. Antibiotic resistance and population structure of cystic fibrosis Pseudomonas aeruginosa isolates from a Spanish multi-centre study.
López-Causapé C; de Dios-Caballero J; Cobo M; Escribano A; Asensio Ó; Oliver A; Del Campo R; Cantón R; Solé A; Cortell I; Asensio O; García G; Martínez MT; Cols M; Salcedo A; Vázquez C; Baranda F; Girón R; Quintana E; Delgado I; de Miguel MÁ; García M; Oliva C; Prados MC; Barrio MI; Pastor MD; Olveira C; de Gracia J; Álvarez A; Escribano A; Castillo S; Figuerola J; Togores B; Oliver A; López C; de Dios Caballero J; Tato M; Máiz L; Suárez L; Cantón R
Int J Antimicrob Agents; 2017 Sep; 50(3):334-341. PubMed ID: 28735882
[TBL] [Abstract][Full Text] [Related]
7. Genetic adaptation of Pseudomonas aeruginosa to the airways of cystic fibrosis patients is catalyzed by hypermutation.
Mena A; Smith EE; Burns JL; Speert DP; Moskowitz SM; Perez JL; Oliver A
J Bacteriol; 2008 Dec; 190(24):7910-7. PubMed ID: 18849421
[TBL] [Abstract][Full Text] [Related]
8. Genomics and Susceptibility Profiles of Extensively Drug-Resistant Pseudomonas aeruginosa Isolates from Spain.
Del Barrio-Tofiño E; López-Causapé C; Cabot G; Rivera A; Benito N; Segura C; Montero MM; Sorlí L; Tubau F; Gómez-Zorrilla S; Tormo N; Durá-Navarro R; Viedma E; Resino-Foz E; Fernández-Martínez M; González-Rico C; Alejo-Cancho I; Martínez JA; Labayru-Echverria C; Dueñas C; Ayestarán I; Zamorano L; Martinez-Martinez L; Horcajada JP; Oliver A
Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28874376
[TBL] [Abstract][Full Text] [Related]
9. Evolution of the Pseudomonas aeruginosa mutational resistome in an international Cystic Fibrosis clone.
López-Causapé C; Sommer LM; Cabot G; Rubio R; Ocampo-Sosa AA; Johansen HK; Figuerola J; Cantón R; Kidd TJ; Molin S; Oliver A
Sci Rep; 2017 Jul; 7(1):5555. PubMed ID: 28717172
[TBL] [Abstract][Full Text] [Related]
10. Wide dispersion of ST175 clone despite high genetic diversity of carbapenem-nonsusceptible Pseudomonas aeruginosa clinical strains in 16 Spanish hospitals.
García-Castillo M; Del Campo R; Morosini MI; Riera E; Cabot G; Willems R; van Mansfeld R; Oliver A; Cantón R
J Clin Microbiol; 2011 Aug; 49(8):2905-10. PubMed ID: 21697331
[TBL] [Abstract][Full Text] [Related]
11. Comparison of three molecular techniques for typing Pseudomonas aeruginosa isolates in sputum samples from patients with cystic fibrosis.
Kidd TJ; Grimwood K; Ramsay KA; Rainey PB; Bell SC
J Clin Microbiol; 2011 Jan; 49(1):263-8. PubMed ID: 21084517
[TBL] [Abstract][Full Text] [Related]
12. In vivo evolution of resistance of Pseudomonas aeruginosa strains isolated from patients admitted to an intensive care unit: mechanisms of resistance and antimicrobial exposure.
Solé M; Fàbrega A; Cobos-Trigueros N; Zamorano L; Ferrer-Navarro M; Ballesté-Delpierre C; Reustle A; Castro P; Nicolás JM; Oliver A; Martínez JA; Vila J
J Antimicrob Chemother; 2015 Nov; 70(11):3004-13. PubMed ID: 26260130
[TBL] [Abstract][Full Text] [Related]
13. Evolved Aztreonam Resistance Is Multifactorial and Can Produce Hypervirulence in
Jorth P; McLean K; Ratjen A; Secor PR; Bautista GE; Ravishankar S; Rezayat A; Garudathri J; Harrison JJ; Harwood RA; Penewit K; Waalkes A; Singh PK; Salipante SJ
mBio; 2017 Oct; 8(5):. PubMed ID: 29089424
[TBL] [Abstract][Full Text] [Related]
14. Genetic relatedness of Pseudomonas aeruginosa isolates among a paediatric cystic fibrosis patient cohort in Ireland.
Logan C; Habington A; Lennon G; Grogan J; Byrne M; O'Leary J; O'Sullivan N
J Med Microbiol; 2012 Jan; 61(Pt 1):64-70. PubMed ID: 21921114
[TBL] [Abstract][Full Text] [Related]
15. Within-host whole genome analysis of an antibiotic resistant Pseudomonas aeruginosa strain sub-type in cystic fibrosis.
Sherrard LJ; Tai AS; Wee BA; Ramsay KA; Kidd TJ; Ben Zakour NL; Whiley DM; Beatson SA; Bell SC
PLoS One; 2017; 12(3):e0172179. PubMed ID: 28273168
[TBL] [Abstract][Full Text] [Related]
16. Twenty-five-year outbreak of Pseudomonas aeruginosa infecting individuals with cystic fibrosis: identification of the prairie epidemic strain.
Parkins MD; Glezerson BA; Sibley CD; Sibley KA; Duong J; Purighalla S; Mody CH; Workentine ML; Storey DG; Surette MG; Rabin HR
J Clin Microbiol; 2014 Apr; 52(4):1127-35. PubMed ID: 24452167
[TBL] [Abstract][Full Text] [Related]
17. Diversity of β-lactam resistance mechanisms in cystic fibrosis isolates of Pseudomonas aeruginosa: a French multicentre study.
Llanes C; Pourcel C; Richardot C; Plésiat P; Fichant G; Cavallo JD; Mérens A;
J Antimicrob Chemother; 2013 Aug; 68(8):1763-71. PubMed ID: 23629014
[TBL] [Abstract][Full Text] [Related]
18. lptG contributes to changes in membrane permeability and the emergence of multidrug hypersusceptibility in a cystic fibrosis isolate of Pseudomonas aeruginosa.
Harrison LB; Fowler RC; Abdalhamid B; Selmecki A; Hanson ND
Microbiologyopen; 2019 Nov; 8(11):e844. PubMed ID: 30977288
[TBL] [Abstract][Full Text] [Related]
19. Spanish nationwide survey on Pseudomonas aeruginosa antimicrobial resistance mechanisms and epidemiology.
Del Barrio-Tofiño E; Zamorano L; Cortes-Lara S; López-Causapé C; Sánchez-Diener I; Cabot G; Bou G; Martínez-Martínez L; Oliver A;
J Antimicrob Chemother; 2019 Jul; 74(7):1825-1835. PubMed ID: 30989186
[TBL] [Abstract][Full Text] [Related]
20. Emergence of a mutL mutation causing multilocus sequence typing-pulsed-field gel electrophoresis discrepancy among Pseudomonas aeruginosa isolates from a cystic fibrosis patient.
García-Castillo M; Máiz L; Morosini MI; Rodríguez-Baños M; Suarez L; Fernández-Olmos A; Baquero F; Cantón R; del Campo R
J Clin Microbiol; 2012 May; 50(5):1777-8. PubMed ID: 22322352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
